Characteristics and 2 ‐year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA‐AF

ConclusionsPatients with AF and history of HF may have greater disease burden at AF diagnosis and increased mortality rates vs. patients without HF. Stroke and major bleeding rates were roughly comparable between groups confirming the long ‐term safety and effectiveness of dabigatran in patients with HF.

Source: ESC Heart Failure - July 1, 2020 Category: Cardiology Authors: Sergio J. Dubner, Christine Teutsch, Menno V. Huisman, Hans ‐Christoph Diener, Jonathan Halperin, Kenneth J. Rothman, Chang‐Sheng Ma, Eduardo Chuquiure‐Valenzuela, Jutta Bergler‐Klein, Kristina Zint, Lionel Riou França, Shihai Lu, Min Tags: Original Research Article Source Type: research